Home » Topics » BioWorld Science

BioWorld Science
RSS

TRAF2 and NCK-interacting protein kinase inhibitors discovered at Silverback Therapeutics

May 14, 2019

NB-01 leads to statistically significant improvements in diabetic neuropathic pain

May 14, 2019

Novel biomarkers of clinical efficacy of bevacizumab in the treatment of gastric cancer

May 14, 2019

WuXi Biologics describes new bispecific antibodies against EGFR and PD-1

May 14, 2019

Updated data presented from phase Ib/II study of RG-6206 in boys with DMD

May 14, 2019

CAR fusion proteins targeting Strep-tagged peptides patented by Fred Hutchinson, TUM

May 14, 2019

Flavonoid promotes pleiotropic neuroprotective effects

May 14, 2019

IMVT-1401 demonstrates promising safety, PK and PD in healthy subjects

May 14, 2019

Long non-coding RNA CASC9 has an oncogenic role in breast cancer

May 14, 2019

Plasma kallikrein inhibitor VE-4840 shows preclinical potential for treating diabetic retinopathy

May 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...